Circulating low density neutrophils are associated with resistance to anti‐PD1 immunotherapy in squamous head and neck cancer
Head & Neck · 2023
DOI: 10.1002/hed.27536 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Head & Neck, 2023. Verfasst von Virginia Arrazubi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Oncobiona Group, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain. Hauptthemen laut MEDLINE: Interleukin-7, Head and Neck Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Sociedad Española de Oncología Médica.
Abstract (Originalsprache)
Background
Identification of predictive biomarkers to Immune checkpoint inhibitors (ICIs) in head and neck cancer (HNSCC) is an unmet need.
Methods
This was a prospective observational study including 25 patients with HNSCC treated with immunotherapy or chemotherapy after a prior platinum‐based regimen. Low density neutrophils (LDNs) and serum markers were analyzed.
Results
In the immunotherapy cohort, patients with high LDN levels had a shorter progression free survival (PFS) (1.8 months vs. 10.9 months; * p = 0.034). Also, progressors showed higher percentage of LDNs compared to non‐progressors although significance was not reached (mean 20.68% vs. 4.095%, p = 0.0875). These findings were not replicated in patients treated with chemotherapy. High levels of interleukin‐7 (IL7) were correlated with a significantly longer overall survival (OS) (13.47 months 3.51 vs. months, * p = 0.013).
Conclusions
High baseline circulating LDNs and low IL7 could identify a subset of patients intrinsically refractory to ICIs as monotherapy in HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oncobiona Group, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
- Medical Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain.
- Oncoimmunology Group, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
- Pathology Department, Hospital Universitario de Navarra, Pamplona, Spain.
ORCID-Profile: Virginia Arrazubi, Saioa Goñi, Hugo Arasanz, Jairo Pérez-Sanz, Ana Isabel Bocanegra, Grazyna Kochan, David Escors, Antonio Viúdez, Ruth Vera
Förderung
- Sociedad Española de Oncología Médica
Zitieren
APA
Arrazubi, V., Goñi, S., González-Borja, I., Hernandez-Garcia, I., Arasanz, H., Pérez-Sanz, J., Bocanegra, A. I., Kochan, G., Escors, D., Ruiz de Azúa, Y., Elizalde, J. M., Viúdez, A., & Vera, R. (2023). Circulating low density neutrophils are associated with resistance to anti‐PD1 immunotherapy in squamous head and neck cancer. Head & Neck. https://doi.org/10.1002/hed.27536
Vancouver
Arrazubi V, Goñi S, González-Borja I, Hernandez-Garcia I, Arasanz H, Pérez-Sanz J, et al. Circulating low density neutrophils are associated with resistance to anti‐PD1 immunotherapy in squamous head and neck cancer. Head & Neck. 2023. doi:10.1002/hed.27536
BibTeX
@article{Arrazubi2023,
author = {Arrazubi, Virginia and Goñi, Saioa and González-Borja, Iranzu and Hernandez-Garcia, Irene and Arasanz, Hugo and Pérez-Sanz, Jairo and Bocanegra, Ana Isabel and Kochan, Grazyna and Escors, David and Ruiz de Azúa, Yerani and Elizalde, Jesús María and Viúdez, Antonio and Vera, Ruth},
title = {Circulating low density neutrophils are associated with resistance to anti‐PD1 immunotherapy in squamous head and neck cancer},
journal = {Head & Neck},
year = {2023},
doi = {10.1002/hed.27536}
}
EUVIMED